Investing carries serious risks, including partial or total loss of capital. Please read the Key Investment Information Sheet and the Risk factors and login before investing.

IRM.Life 1A

Wireless Energy & Data Infrastructure for Medical Devices
Key Investment Information Sheet Terms & Conditions
Equity
€600,850
total amount raised in round
403%
Financed 403%
  • Eligible for a tax reduction

DISCLAIMER

Every investment decision must be based on an examination of an exhaustive set of information provided by the entrepreneur on their online profile. Spreds only proceeds to a limited verification of this information and does not control the investment opportunity within this company. Spreds did not verify the extent to which the business plan is deemed realistic and does not intervene in determining the final terms of the investment, including the retained maximum valuation. Spreds will align itself with the financial terms negotiated with the co-investor(s).

The next clinical infrastructure layer: Wireless energy and telemetry for hospitals


IRM.Life is a healthcare commercialization company built on biaNergy's protected technology Magnetic Resonance Technology-Extended (MRT-E). It provides safely over-the-air the room-level energy, device interface and monitoring layer needed to use controlled and safe wireless energy transmission and telemetry (data transition and managenemt) in regulated clinical environments - without cable, batteries or touch mat.

The first focus is compatible low-power devices, sealed accessories, point-of-care workflows, wearables and hospital sensors, displays and HIoTs that can benefit from a shared room system and reduce cost, infection, environmental pollution spatial freedom to patients along with better, faster care in hospitals.



Hospital room of today and tomorrow




The Problem: hospital power burden


Hospitals depend on thousands of devices, sensors and accessories. Many have their own battery, charger, cable, connector and maintenance routine. Staff must repeatedly find, charge, clean, inspect and repair them.

Across many rooms and shifts, this creates avoidable work, equipment downtime, cleaning challenges and operational risk. The burden is strongest where unsealed accessories such as wearable monitors and low-power sensors sit close to the patients. It is not only hard to make them continuously available but these devices cause 15% of the infections.


Estimated annual burden for a typical 400-bed hospital

·       Search and lost staff time: €1.095M, including time spent finding, charging and reconnecting devices.
·       Hygiene: €468K, including cleaning work around cables, chargers and battery compartments.
·       Infection treatment: €350K, representing an estimated treatment burden linked to avoidable contamination risk.
·       Maintenance: €210K, including battery replacement and connector repair.
·       Operational risk: €75K, including insurance and operational disruption.

The cost is not one single invoice. It is spread across staff time, consumables, cleaning, maintenance, equipment availability, infection-control processes and operational interruptions. That fragmentation makes the problem easy to tolerate but difficult to solve device by device.



The Solution: IRM-Life and all sides win!


Making energy and data in health technology as easy as wifi for internet available at distance, across levels, simultaneously feeding up to 20 receivers, IRM.Life sets new standards for clinical environments. With that IRM.Life enables; New markets for OEMs (Device Producers), Enormous Financial Savings for Hospitals, More Safety and Less Burden for Patients, Cleaner Environment for all: One managed clinical-room layer for energy enable device manufacturers to produce sealed devices to the. benefit of the patients and hospitals.


Four connected elements

·       The transmitter. A wall- or ceiling-mounted unit creates a controlled energy field within a defined, mapped room and sends low level of energy across the room. A 7 m reach-range is a configuration-dependent reference point.
·       Spatial field. The room environment is turned to an energy-field by the transmitter (or modem) to which connected devices can operate within a validated power and performance envelope disregarding spatial alignment - unlike a charging pad, which needs exact placement, MRT-E is designed NLoS for mapped, reflection-aware room operation.
·       The receiver. A small receiver and power-management interface are integrated into compatible devices serially captures the energy and operates the device through power-management 
·       Device and control layer. Software manages device identity, configuration, connection status, monitoring and defined safety controls via staff mobile, PC or back office.




The investment case


€3.0M Seed raise | €7.85M pre-money valuation | €10.85M post-money valuation

For complete hospital-room validation, medical-device integration, safety testing and readiness for commercial deployment within 24 months.

  • Commercial traction already exists. IRM.Life has signed a €5.6M contract—almost twice the amount being raised. Revenue will follow the agreed acceptance and licensing conditions. The wider weighted commercial pipeline exceeds €16M.

  • The customer benefit is clear. IRM.Life estimates that batteries, cables and charging routines cost a typical 400-bed hospital €2.198M each year. Against a reference €2.0M licence, the model indicates a payback period of approximately 11 months. Hospital pilots will be used to confirm these savings.

  • The underlying MRT-E technology is already technically mature. The Seed round funds its adaptation and validation for healthcare, rather than the development of the core technology from the beginning.

  • Timely break-even. The financial model assumes two licence-equivalent conversions latest at the end of Year 2 enabling break-even reached in Year 3. EBITDA becomes positive in Year 3 and cumulative cash becomes positive in Year 4.

As technology designer IRM.Life can scale through three-to-five-year B2B licenses without manufacturing medical device itself.



Significant innovation that can potentionally reach a very large market. Seems like sale to a large OEM would be an orderly and straightforward way to exit.
             — Christian Caroll, Investor, GE International


What changes for the hospitals

Today, each device usually brings its own charging routine, connector, battery cycle and the maintenance burden.

IRM.Life offers a different path: Using the MRT-E platform enables
  • No battery handling.
  • Fewer cable and charging routines.
  • One managed infrastructure layer.

✓  A hospital device could work without an exposed battery compartment or cable and became more immune to bacteria and virus exposure.
✓  A wearable monitor could operate and support while the patient moves around the room.
✓  Sensors could report their identity and status and diagnostic data through one room dashboard.
✓  A room dashboard can show data of the patient and connected device while data are stored and managed in the back office.

The room becomes the shared delivery and monitoring environment. Energy does not need to be managed by one charger (battery or cable) at a time. It can flow through clinical space - supporting compatible low-power devices around the patient and care team.



An IRM.Life transmitter wirelessly supplies energy to the devices throughout the hospital room. (The transmitter is intentionally depicted at an enlarged scale for better visibility.)



Who buys or licenses the product?

IRM.Life plans to earn revenue from licences, integration work, software and support. There are two connected customer routes:

✓  Medical-device manufacturers or distributors (OEMs) license by annual subscription the receiver design and integration tools for their own products.
✓  Hospitals, or their infrastructure partners, pay for the room system, software and agreed support.

The contract can differ by project and subscription period. IRM.Life supports the shared technology; each OEM (device manufacturer) remains responsible for the approval and performance of its own medical device.



Safety and Regulation


IRM.Life focuses on low-power medical and healthcare devices, not for replacing mains electricity or powering high-load equipment.
The system is being developed for operation within applicable ETSI and FCC regulatory limits, with planning scenarios of up to 4 W in the EU and up to 6 W in selected non-EU markets, subject to the relevant requirements.

Device based tests indicate exposure levels as being well below referenced public safety limits. IRM.Life is designed for safe operation around people, medical devices and surrounding equipment, with protection against any harmful electromagnetic interference,

IRM.Life is being supported by InnHealthium on its Regulatory-Compliance pathway. (For more see please related documentation in the attachment)



Spatial freedom to patients while their wearables and on-body devices being safely energized.




Technology readiness

IRM.Life treats the core MRT-E engine as TRL 8. TRL 9 applies only where market use is proven. Current evidence supports engineering feasibility and pilot readiness; hospital deployment still requires clinical-environment validation, OEM or hospital integration.


IP rights and patents

The system-level IP position of biaNergy (Nicola BV), on which IRM.Life is based, is anchored by published European Patent Office document EP4 679 673 A1, application EP24 188 458.4. The source materials identify eight published core assets. Further claim areas are 22 preparation-stage extension assets being in application phase for application.


Scientific and regulatory cooperation

Named cooperation partners in the source materials include InnHealthium, UCL, VTT Technical Research Centre of Finland and TU Eindhoven.



Really innovative. IRM.Life will have a great future.
— Javier Robledo, NextGeneration EU



(All related data in this presentation are sourced from Statista, ECDC Europe, GE Healthcare, Eurostat, Mordor Intelligence, ASHE Benchmarking “Medical Equipment Maintenance Report”)

TAX SHELTER 45%

Investments in this company benefit from a 45% personal income tax reduction. Read more…
A remaining amount of €91,050 is available for the Tax Shelter benefit.

Raise summary

Crowd investments €100,850
Committed by others €500,000
Amount raised €600,850
Minimum round €25,000
Maximum round €3,000,000
Shares in the company (total round) 28.571%
Pre-money valuation €7,500,000
Post-money valuation min. €7,525,000
Post-money valuation max. €10,500,000